New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 31, 2014
10:10 EDTORPNBio Blast Pharma opens at $10.90, IPO priced at $11.00
Bio Blast Pharma priced 3.2M shares at $11.00. Oppenheimer and Roth Capital acted as joint book running managers for the offering.
News For ORPN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 26, 2014
08:04 EDTORPNBio Blast Pharma decline not based on fundamentals, says Oppenheimer
Subscribe for More Information
November 21, 2014
08:09 EDTORPNBio Blast Pharma reports Q3 EPS (16c), consensus (9c)
Subscribe for More Information
November 19, 2014
09:04 EDTORPNBio Blast Pharma's Cabaletta granted Orphan Drug Designation by FDA
Subscribe for More Information
November 18, 2014
14:09 EDTORPNBio Blast Pharma's trehalose receives FDA orphan designation
Subscribe for More Information
November 14, 2014
10:25 EDTORPNBio Blast Pharma management to meet with Roth Capital
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use